Jonathan Anomaly

Jonathan Anomaly, Director of Research at Herasight and bioethicist, joins to discuss groundbreaking advancements in embryo genetic selection. He reveals how Herasight offers superior polygenic risk scores and addresses the controversy surrounding Nucleus Genomics. The conversation dives into the benefits of selecting for intelligence, including better health and lower addiction rates. Anomaly explains pleiotropy's positive outcomes, the ethical implications of germline gene editing, and the need for wider access to these technologies for healthier future generations.

Dr. Jonathan Anomaly, a philosopher and bioethics expert, dives into the intriguing world of embryo selection and its potential impact on intelligence. He discusses how polygenic scores are constructed and the realistic IQ gains from selecting embryos, revealing that many parents prioritize disease risk over IQ. Anomaly also tackles ethical concerns surrounding genetic choices, the limitations of current gene editing technologies, and potential societal effects of modest IQ shifts. Their conversation raises critical questions about voluntary selection versus state interventions in genetics.